Researchers reveal CAR-enhancer therapy could help overcome cancer relapse
Cancer is estimated to affect more than three million people living in the UK, according to Macmillan Cancer Support
Read More
Tag: Dana-Farber Cancer Institute
Dana-Farber Cancer Institute and OncoHost partner for renal cell carcinoma research
Accounting for 4% of all cases, kidney cancer is currently the sixth most common cancer diagnosed in the UK
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
